Caidya is a global, full-service biopharma CRO that partners with pharmaceutical innovators to navigate the drug development process. The company offers expertise across clinical development, operations, regulatory services, pharmacovigilance, and data technology, with a focus on patient-centric study delivery and flexible models. It operates with a global reach, running studies in over 40 countries and regions to access diverse patient populations and deliver high-quality data for decision-making. Caidya emphasizes collaboration, ownership, and agile execution to accelerate therapy development in areas including oncology, dermatology, rare diseases, and cell and gene therapy.
No recent news for this company.
No recent deals for this company.